DEF 14A

Company

Anika Therapeutics, Inc.

Filed

April 28, 2017

Period of Report

June 13, 2017

Accession Number

0001171843-17-002415

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →